Report Detail

Pharma & Healthcare Global Killed-type Poultry Vaccine Market Research Report 2022

  • RnM4454473
  • |
  • 16 June, 2022
  • |
  • Global
  • |
  • 98 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Industry Insights
Due to the COVID-19 pandemic, the global Killed-type Poultry Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Killed-type Poultry Vaccine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Killed-type Poultry Vaccine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

NDV accounting for % of the Killed-type Poultry Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Chicken segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Killed-type Poultry Vaccine include MERCK, Boehringer Ingelheim, CEVA, ZOETIS, Vaxxinova, ELANCO, QYH BIOTECH, PULIKE and PHIBRO ANIMAL HEALTH CORPORATION, etc. In terms of revenue, the global 3 largest players have a % market share of Killed-type Poultry Vaccine in 2021.

This report focuses on Killed-type Poultry Vaccine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Killed-type Poultry Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Killed-type Poultry Vaccine market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

NDV

Marek ' s Disease

IBD

Infectious Bronchitis

Influenza

Other

Segment by Application

Chicken

Other Poultry

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

MERCK

Boehringer Ingelheim

CEVA

ZOETIS

Vaxxinova

ELANCO

QYH BIOTECH

PULIKE

PHIBRO ANIMAL HEALTH CORPORATION

JINYU BIOTECHNOLOGY

HARBIN PHARMACEUTICAL GROUP

MEVAC

VENKY’S

Frequently Asked Questions

Which product segment grabbed the largest share in the Killed-type Poultry Vaccine market?

How is the competitive scenario of the Killed-type Poultry Vaccine market?

Which are the key factors aiding the Killed-type Poultry Vaccine market growth?

Which are the prominent players in the Killed-type Poultry Vaccine market?

Which region holds the maximum share in the Killed-type Poultry Vaccine market?

What will be the CAGR of the Killed-type Poultry Vaccine market during the forecast period?

Which application segment emerged as the leading segment in the Killed-type Poultry Vaccine market?

What key trends are likely to emerge in the Killed-type Poultry Vaccine market in the coming years?

What will be the Killed-type Poultry Vaccine market size by 2028?

Which company held the largest share in the Killed-type Poultry Vaccine market?


1 Killed-type Poultry Vaccine Market Overview

  • 1.1 Product Overview and Scope of Killed-type Poultry Vaccine
  • 1.2 Killed-type Poultry Vaccine Segment by Type
  • 1.2.1 Global Killed-type Poultry Vaccine Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 NDV
  • 1.2.3 Marek ' s Disease
  • 1.2.4 IBD
  • 1.2.5 Infectious Bronchitis
  • 1.2.6 Influenza
  • 1.2.7 Other
  • 1.3 Killed-type Poultry Vaccine Segment by Application
  • 1.3.1 Global Killed-type Poultry Vaccine Sales Comparison by Application: (2022-2028)
  • 1.3.2 Chicken
  • 1.3.3 Other Poultry
  • 1.4 Global Killed-type Poultry Vaccine Market Size Estimates and Forecasts
  • 1.4.1 Global Killed-type Poultry Vaccine Revenue 2017-2028
  • 1.4.2 Global Killed-type Poultry Vaccine Sales 2017-2028
  • 1.4.3 Killed-type Poultry Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
  • 2 Killed-type Poultry Vaccine Market Competition by Manufacturers

    • 2.1 Global Killed-type Poultry Vaccine Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Killed-type Poultry Vaccine Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Killed-type Poultry Vaccine Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Killed-type Poultry Vaccine Manufacturing Sites, Area Served, Product Type
    • 2.5 Killed-type Poultry Vaccine Market Competitive Situation and Trends
    • 2.5.1 Killed-type Poultry Vaccine Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Killed-type Poultry Vaccine Players Market Share by Revenue
  • 2.5.3 Global Killed-type Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 3 Killed-type Poultry Vaccine Retrospective Market Scenario by Region

    • 3.1 Global Killed-type Poultry Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Killed-type Poultry Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Killed-type Poultry Vaccine Market Facts & Figures by Country
    • 3.3.1 North America Killed-type Poultry Vaccine Sales by Country
  • 3.3.2 North America Killed-type Poultry Vaccine Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
  • 3.4 Europe Killed-type Poultry Vaccine Market Facts & Figures by Country
  • 3.4.1 Europe Killed-type Poultry Vaccine Sales by Country
  • 3.4.2 Europe Killed-type Poultry Vaccine Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
  • 3.5 Asia Pacific Killed-type Poultry Vaccine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Killed-type Poultry Vaccine Sales by Region
  • 3.5.2 Asia Pacific Killed-type Poultry Vaccine Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.6 Latin America Killed-type Poultry Vaccine Market Facts & Figures by Country
  • 3.6.1 Latin America Killed-type Poultry Vaccine Sales by Country
  • 3.6.2 Latin America Killed-type Poultry Vaccine Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
  • 3.7 Middle East and Africa Killed-type Poultry Vaccine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Killed-type Poultry Vaccine Sales by Country
  • 3.7.2 Middle East and Africa Killed-type Poultry Vaccine Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE
  • 4 Global Killed-type Poultry Vaccine Historic Market Analysis by Type

    • 4.1 Global Killed-type Poultry Vaccine Sales Market Share by Type (2017-2022)
    • 4.2 Global Killed-type Poultry Vaccine Revenue Market Share by Type (2017-2022)
    • 4.3 Global Killed-type Poultry Vaccine Price by Type (2017-2022)

    5 Global Killed-type Poultry Vaccine Historic Market Analysis by Application

    • 5.1 Global Killed-type Poultry Vaccine Sales Market Share by Application (2017-2022)
    • 5.2 Global Killed-type Poultry Vaccine Revenue Market Share by Application (2017-2022)
    • 5.3 Global Killed-type Poultry Vaccine Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 MERCK
    • 6.1.1 MERCK Corporation Information
  • 6.1.2 MERCK Description and Business Overview
  • 6.1.3 MERCK Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 MERCK Killed-type Poultry Vaccine Product Portfolio
  • 6.1.5 MERCK Recent Developments/Updates
  • 6.2 Boehringer Ingelheim
  • 6.2.1 Boehringer Ingelheim Corporation Information
  • 6.2.2 Boehringer Ingelheim Description and Business Overview
  • 6.2.3 Boehringer Ingelheim Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 Boehringer Ingelheim Killed-type Poultry Vaccine Product Portfolio
  • 6.2.5 Boehringer Ingelheim Recent Developments/Updates
  • 6.3 CEVA
  • 6.3.1 CEVA Corporation Information
  • 6.3.2 CEVA Description and Business Overview
  • 6.3.3 CEVA Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 CEVA Killed-type Poultry Vaccine Product Portfolio
  • 6.3.5 CEVA Recent Developments/Updates
  • 6.4 ZOETIS
  • 6.4.1 ZOETIS Corporation Information
  • 6.4.2 ZOETIS Description and Business Overview
  • 6.4.3 ZOETIS Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 ZOETIS Killed-type Poultry Vaccine Product Portfolio
  • 6.4.5 ZOETIS Recent Developments/Updates
  • 6.5 Vaxxinova
  • 6.5.1 Vaxxinova Corporation Information
  • 6.5.2 Vaxxinova Description and Business Overview
  • 6.5.3 Vaxxinova Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 Vaxxinova Killed-type Poultry Vaccine Product Portfolio
  • 6.5.5 Vaxxinova Recent Developments/Updates
  • 6.6 ELANCO
  • 6.6.1 ELANCO Corporation Information
  • 6.6.2 ELANCO Description and Business Overview
  • 6.6.3 ELANCO Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 ELANCO Killed-type Poultry Vaccine Product Portfolio
  • 6.6.5 ELANCO Recent Developments/Updates
  • 6.7 QYH BIOTECH
  • 6.6.1 QYH BIOTECH Corporation Information
  • 6.6.2 QYH BIOTECH Description and Business Overview
  • 6.6.3 QYH BIOTECH Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 QYH BIOTECH Killed-type Poultry Vaccine Product Portfolio
  • 6.7.5 QYH BIOTECH Recent Developments/Updates
  • 6.8 PULIKE
  • 6.8.1 PULIKE Corporation Information
  • 6.8.2 PULIKE Description and Business Overview
  • 6.8.3 PULIKE Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 PULIKE Killed-type Poultry Vaccine Product Portfolio
  • 6.8.5 PULIKE Recent Developments/Updates
  • 6.9 PHIBRO ANIMAL HEALTH CORPORATION
  • 6.9.1 PHIBRO ANIMAL HEALTH CORPORATION Corporation Information
  • 6.9.2 PHIBRO ANIMAL HEALTH CORPORATION Description and Business Overview
  • 6.9.3 PHIBRO ANIMAL HEALTH CORPORATION Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 PHIBRO ANIMAL HEALTH CORPORATION Killed-type Poultry Vaccine Product Portfolio
  • 6.9.5 PHIBRO ANIMAL HEALTH CORPORATION Recent Developments/Updates
  • 6.10 JINYU BIOTECHNOLOGY
  • 6.10.1 JINYU BIOTECHNOLOGY Corporation Information
  • 6.10.2 JINYU BIOTECHNOLOGY Description and Business Overview
  • 6.10.3 JINYU BIOTECHNOLOGY Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 JINYU BIOTECHNOLOGY Killed-type Poultry Vaccine Product Portfolio
  • 6.10.5 JINYU BIOTECHNOLOGY Recent Developments/Updates
  • 6.11 HARBIN PHARMACEUTICAL GROUP
  • 6.11.1 HARBIN PHARMACEUTICAL GROUP Corporation Information
  • 6.11.2 HARBIN PHARMACEUTICAL GROUP Killed-type Poultry Vaccine Description and Business Overview
  • 6.11.3 HARBIN PHARMACEUTICAL GROUP Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 HARBIN PHARMACEUTICAL GROUP Killed-type Poultry Vaccine Product Portfolio
  • 6.11.5 HARBIN PHARMACEUTICAL GROUP Recent Developments/Updates
  • 6.12 MEVAC
  • 6.12.1 MEVAC Corporation Information
  • 6.12.2 MEVAC Killed-type Poultry Vaccine Description and Business Overview
  • 6.12.3 MEVAC Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.12.4 MEVAC Killed-type Poultry Vaccine Product Portfolio
  • 6.12.5 MEVAC Recent Developments/Updates
  • 6.13 VENKY’S
  • 6.13.1 VENKY’S Corporation Information
  • 6.13.2 VENKY’S Killed-type Poultry Vaccine Description and Business Overview
  • 6.13.3 VENKY’S Killed-type Poultry Vaccine Sales, Revenue and Gross Margin (2017-2022)
  • 6.13.4 VENKY’S Killed-type Poultry Vaccine Product Portfolio
  • 6.13.5 VENKY’S Recent Developments/Updates
  • 7 Killed-type Poultry Vaccine Manufacturing Cost Analysis

    • 7.1 Killed-type Poultry Vaccine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Killed-type Poultry Vaccine
  • 7.4 Killed-type Poultry Vaccine Industrial Chain Analysis
  • 8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Killed-type Poultry Vaccine Distributors List
    • 8.3 Killed-type Poultry Vaccine Customers

    9 Killed-type Poultry Vaccine Market Dynamics

    • 9.1 Killed-type Poultry Vaccine Industry Trends
    • 9.2 Killed-type Poultry Vaccine Market Drivers
    • 9.3 Killed-type Poultry Vaccine Market Challenges
    • 9.4 Killed-type Poultry Vaccine Market Restraints

    10 Global Market Forecast

    • 10.1 Killed-type Poultry Vaccine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Killed-type Poultry Vaccine by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Killed-type Poultry Vaccine by Type (2023-2028)
  • 10.2 Killed-type Poultry Vaccine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Killed-type Poultry Vaccine by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Killed-type Poultry Vaccine by Application (2023-2028)
  • 10.3 Killed-type Poultry Vaccine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Killed-type Poultry Vaccine by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Killed-type Poultry Vaccine by Region (2023-2028)
  • 11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
    • 12.1.2 Market Size Estimation
    • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
    • 12.2.1 Secondary Sources
    • 12.2.2 Primary Sources
    • 12.3 Author List
    • Summary:
      Get latest Market Research Reports on Killed-type Poultry Vaccine. Industry analysis & Market Report on Killed-type Poultry Vaccine is a syndicated market report, published as Global Killed-type Poultry Vaccine Market Research Report 2022. It is complete Research Study and Industry Analysis of Killed-type Poultry Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,363.50
      4,727.00
      2,743.40
      5,486.80
      392,341.00
      784,682.00
      227,128.00
      454,256.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report